Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.575T
Market Weight
11.11%
Industries
11
Companies
1213
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
DELL

Day Return

Sector
0.02%
S&P 500
1.85%

YTD Return

Sector
3.88%
S&P 500
9.49%

1-Year Return

Sector
5.89%
S&P 500
26.79%

3-Year Return

Sector
9.11%
S&P 500
23.39%

5-Year Return

Sector
66.50%
S&P 500
85.74%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
3.88%
Drug Manufacturers - General
33.97%
9.26%
Healthcare Plans
13.31%
-3.68%
Medical Devices
12.77%
4.42%
Diagnostics & Research
11.66%
6.00%
Biotechnology
11.30%
-4.36%
Medical Instruments & Supplies
6.62%
3.83%
Medical Care Facilities
2.97%
13.99%
Drug Manufacturers - Specialty & Generic
2.76%
-4.25%
Medical Distribution
2.36%
9.50%
Health Information Services
2.06%
5.21%
Pharmaceutical Retailers
0.23%
-33.77%

Note: Percentage % data on heatmap indicates Day Return

All Industries

Largest Companies in This Sector

Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
760.00 856.61 11.19% 722.308B -1.50% +30.38%
Buy
512.81 566.61 7.31% 471.983B +1.14% -2.59%
Buy
149.91 172.72 5.59% 360.785B +0.04% -4.36%
Buy
130.06 141.42 5.10% 329.417B -0.13% +19.30%
Buy
160.75 182.41 4.40% 283.864B +0.22% +3.73%
Buy
593.03 622.29 3.51% 226.369B +2.61% +11.73%
Buy
253.38 271.39 2.91% 187.675B +0.78% +9.53%
Buy
104.74 126.23 2.82% 182.209B +0.07% -4.84%
Buy
310.15 316.41 2.58% 166.375B -0.87% +7.68%
Buy
28.01 31.37 2.46% 158.721B -0.60% -2.71%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
143.59 37.936B 0.09% +5.29%
262.19 20.002B 0.10% +4.58%
133.40 6.991B 0.45% -1.80%
88.14 6.358B 0.35% -1.29%
55.83 5.241B 0.40% +3.45%

Mutual Fund Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
212.95 45.706B 0.29% +1.84%
89.79 45.706B 0.29% +1.84%
131.21 20.002B 0.10% +4.62%
92.43 14.712B 0.80% +4.89%
92.16 14.487B 0.80% +4.85%

Healthcare Research

Discover the Latest Analyst and Technical Research for This Sector

  • Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

    In this edition, we assess exposure of some consumer finance banks; Compass Minerals puts its dividend on ice; Humana's stock pitch shows a rare opportunity; and Enel SpA, Warner Bros. Discovery, and Puma.

     
  • Analyst Report: HCA Healthcare, Inc.

    HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2022, the firm owned and operated 182 hospitals, 126 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.

    Rating
    Price Target
     
  • Analyst Report: Guardant Health, Inc.

    Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

    Rating
    Price Target
     
  • Analyst Report: Mettler-Toledo International Inc.

    Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences, industrial, and food retail industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with sales distribution roughly as follows: United States around 30% of sales, Europe around 30%, China around 20%, and the rest of the world around 20%.

    Rating
    Price Target
     

From the Community

Healthcare News